Heart Failure - PROACTIVE-HF TRIAL
A Prospective, Multi-Center, Randomized, Controlled, Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients
Dr. Jason Gluck is participating in this trial collecting information which will provide clinicians with a better understanding of the Cordella PA Sensor System as a potential solution for proactive Heart Failure management, early detection of fluid overload and possibly the prevention of worsening Heart Failure symptoms.
Eligibility Criteria
- Patients on medical therapy according to the current American Heart Association guidelines
- Hospitalized for Heart Failure within the last year
Please contact Khadija El Aoudi at 860-972-3167 or by email [email protected] for more information